Medicine Insight is a national Health Information program run by NPS Medicine Wise and funded by the Australian Government Department of Health.
Medicine Insight collects information from your medical record about your medical history, health care and lifestyle. Information that identifies you such as your name, date of birth and address is not collected. Important steps are taken to ensure that patient's privacy and security are protected.
Patient's information is used to improve the quality of health care that is provided to them, for health research and to inform health policy.
CARNOSINE TRIAL (DIABETES PREVENTION TRIAL) 2017 - Current
This Diabetes Prevention study was created by Monash Health and Monash University. The study investigates the effect of Carnosine, an anti-aging over the counter food supplement on type 2 diabetes, cognitive function and cardiovascular disease prevention.
Carnosine trial (Insulin Sensitivity) 2018 - Current
This second trial focuses on Carnosine and if it leads to improvements in insulin sensitivity (and therefore Diabetes), Cognitive Functioning and Cardiovascular Disease progression.
Participants must be overweight (BMI >25) but otherwise healthy.
This trial is almost identical to the Carnosine (Diabetes Prevention Trial) in terms of tests performed however there is some additional procedures and time commitment (3-4 baseline visits, 3-4 follow up visits total). Both studies are carried out at the Monash Medical Centre in Clayton.
EARLY DETECTION OF PRIMARY ALDOSTERONISM 2017 - current
This Study is run by Jun (Endocrinologist at Monash Health). Primary Aldosteronism is a potentially curable cause of hypertension. This study will find out exactly how common Primary Aldosteronism is in our community; Identify patients with Primary Aldosteronism as early as possible to optimise their health and reshape future hypertension management guidelines.
All doctors at this clinic are involved in this study.
3 x BP above 140 / 90 no medication
needs htn screen including uec, aldosteron, renin, aldorenin ratio (needs to be done 2 hrs post getting out of bed - approx 8-10am)
Statins in reducing events in the elderly through Monash & other Uni's. There is some evidence that Statins may reduce decline in physical and mental function as well as reducing the incidence of heart disease, stroke and dementia. Therefore, Statin treatment may help to prolong healthy, independent living.
Eligibility: Anybody over 75 Years +
Dr Tony Atkins & Dr Anna Dowling are the only doctors involved in this study, therefor your appointment needs to be booked in with them.
Impact was a program created by Monash University & Monash Health. This study was aimed at patients attending local government health services who don't have a source of quality GP care.
All doctor's at this clinic were involved in the program.
There were NO Eligibility requirements, this study accepted patients of all ages.
RESET STUDY jan 2017 - dec 2017
Last year (2017) Dr Tony Atkins was involved in the RESET study. The study focused on patients with Hypertension (High Blood Pressure). In the below video clip, Dr Atkins explains in detail what the RESET study was about and the role he played alongside his patients.
Currently we are not involved in the study but the above studies are still available be part of if you meet the criteria.